Treatment of female pattern hair loss with oral antiandrogen

Dedicated to discussions and support for women suffering from hair loss.

Moderator: moderators

Post Reply
User avatar
Site Admin
Posts: 1218
Joined: Sun Aug 24, 2003 3:24 am
Hair Loss Type: Androgenetic Alopecia (Male Pattern Baldness)
Norwood Level: Norwood III Vertex
Have you had a hair transplant?: Yes

Treatment of female pattern hair loss with oral antiandrogen

Post by » Thu Mar 24, 2005 12:26 am

A good study on the use of oral antiandrogens for FPB:
British Journal of Dermatology
Volume 152 Issue 3 Page 466 - March 2005

Treatment of female pattern hair loss with oral antiandrogens
R. Sinclair, M. Wewerinke and D. Jolley


Background: It has not been conclusively established that female pattern hair loss (FPHL) is either due to androgens or responsive to oral antiandrogen therapy.

Objectives: To evaluate the efficacy of oral antiandrogen therapy in the management of women with FPHL using standardized photographic techniques (Canfield Scientific), and to identify clinical and histological parameters predictive of clinical response.

Methods: For this single-centre, before-after, open intervention study, 80 women aged between 12 and 79 years, with FPHL and biopsy-confirmed hair follicle miniaturization [terminal/vellus (T/V) hair ratio <= 4 : 1] were photographed at baseline and again after receiving a minimum of 12 months of oral antiandrogen therapy. Forty women received spironolactone 200 mg daily and 40 women received cyproterone acetate, either 50 mg daily or 100 mg for 10 days per month if premenopausal. Women using topical minoxidil were excluded. Standardized photographs of the midfrontal and vertex scalp were taken with the head positioned in a stereotactic device. Images were evaluated by a panel of three clinicians experienced in the assessment of FPHL, blinded to patient details and treatment and using a three-point scale.

Results: As there was no significant difference in the results or the trend between spironolactone and cyproterone acetate the results were combined. Thirty-five (44%) women had hair regrowth, 35 (44%) had no clear change in hair density before and after treatment, and 10 (12%) experienced continuing hair loss during the treatment period. Ordinal logistic regression analysis to identify predictors of response revealed no influence of patient age, menopause status, serum ferritin, serum hormone levels, clinical stage (Ludwig) or histological parameters such as T/V ratio or fibrosis. The only significant predictor was midscalp clinical grade, with higher-scale values associated with a greater response (P = 0013).

Conclusion: Eighty-eight percent of women receiving oral antiandrogens could expect to see no progression of their FPHL or improvement. High midscalp clinical grade was the only predictor of response identified. A placebo-controlled study is required to compare this outcome to the natural history of FPHL.

User avatar
Prolific Poster
Posts: 325
Joined: Thu Jun 03, 2004 5:19 am
Hair Loss Type: Don't Know
Have you had a hair transplant?: No

Post by Tricia » Sun Mar 27, 2005 8:20 am

Good study. I wonder why they say spiro works for women, but not propecia.
5% minoxidil
Multivitamin with iron

Regular Poster
Posts: 36
Joined: Thu May 23, 2013 1:19 am
Hair Loss Type: Don't Know
Have you had a hair transplant?: No

Re: Treatment of female pattern hair loss with oral antiandrogen

Post by shinning_like_me » Mon Jun 03, 2013 5:55 am

thank u for the post dear!

Post Reply

Who is online

Users browsing this forum: No registered users and 1 guest